Company Tagline
Life Science Investing
Industry Category
Business Keywords
Company Description
Abingworth is a premier transatlantic life sciences investment firm dedicated to converting pioneering science into innovative medicines. Through strategic capital and expert guidance, Abingworth empowers exceptional management teams in building world-class companies.
With a rich history dating back to 1973, Abingworth has invested in over 180 life science ventures, resulting in 46 mergers and acquisitions, and over 70 initial public offerings. Our investment approach focuses on three key areas: seed and early-stage ventures, development-stage companies, and clinical co-development initiatives. Abingworth has offices at 38 Jermyn Street, London, UK, SW1Y 6DN, GB; 3000 Sand Hill Road, B4-135, Menlo Park, CA CA 94025, US; and 420 Boylston Street, Suite 405, Boston, MA 02116, US.
Abingworth supports its portfolio companies with a team of seasoned professionals. Abingworth became part of Carlyle (NASDAQ: CG) on August 1, 2022. We invite the management team at Abingworth to further enrich our platform by creating a customized and exclusive company showcase and product listing.
Key Personnel / Employees
Similar Companies
Other organizations in the same industry
Middle East Venture Partners (MEVP)
Venture-Capital-and-Private-Equity-PrincipalsMiddle East Venture Partners (MEVP) is the Pioneer and one of the largest and most active venture ca...
Pathway to Cures
Venture-Capital-and-Private-Equity-PrincipalsDriving Transformation for All People Living with Inheritable Blood and Bleeding Disorders.
Techstars Sustainability Paris
Venture-Capital-and-Private-Equity-PrincipalsWe invest in early stage high-growth startups looking to build a better future thanks to technology,...
Alternative Company Names
This company is also known as